INS and polycystic ovary syndrome: The included articles dealt with “HS manifestation and exacerbation” (7%), “sexual hormones” (14%), “anti-androgen therapy” (29%), “thyroid function” (21%), “polycystic ovary syndrome” (5%), and “insulin resistance and adipokines” (24%).